Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Evoco Limited has 2 pending office actions in the Chemistry & Materials technology area. These 2 actions are split between 2 distinct examiners and 2 distinct art units. This indicates that each pending matter is being examined in a different technical group by a different individual, reflecting a lack of technical overlap in the current filings.
Larissa Rowe Emrich is the busiest examiner for the portfolio, currently handling 1 pending office action. With only 2 pending actions total, Emrich is responsible for one of the company's current matters. The busiest examiner pending count of 1 shows that no single examiner is managing more than one case for this company at this time.
The use of 2 distinct art units for just 2 pending office actions highlights the technical diversity of these filings within the Chemistry & Materials field. Practitioners should be prepared for different examination approaches, as 2 distinct examiners are involved across different technical groups. This decentralized structure for a small portfolio means that the prosecution of each matter will likely proceed independently of the other.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EMRICH, LARISSA ROWE | 1 | 48.3% | +41.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19331974 | POLYALKYLENE GLYCOL TERMINATED POLY-CARBODIIMIDES, AND PROCESS FOR FORMING SAME | EMRICH, LARISSA ROWE | — |
| Art Unit | Apps |
|---|---|
| 1789 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19331974 | POLYALKYLENE GLYCOL TERMINATED POLY-CARBODIIMIDES, AND PROCESS FOR FORMING SAME | EMRICH, LARISSA ROWE | 1789 | §103§112DP | Non-Final OA | — | Pending | Sep 17, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEvoco Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Larissa Rowe Emrich has the most, with 1 of Evoco Limited's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
